Cardinal Health, Inc. (CAH) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.14%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 7.51×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.14% | Share-based compensation / revenue. Period ending 2026-06-30. $367.00M ÷ $254.25B × 100 ≈ 0.14% |
| Interest coverage · 12 months | 7.51× | Operating income ÷ reported interest expense. $2.61B ÷ $348.00M ≈ 7.51× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 254.25B USD | |
| Stock-based compensation | 367.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.61B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 348.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $254.25B | $367.00M | $2.61B | $348.00M | (m) | 0.14% | 7.51× | Reported |
| 2025-12-31 | (m) | $244.67B | $364.00M | $2.53B | $316.00M | (m) | 0.15% | 8.02× | Reported |
| 2025-09-30 | (m) | $234.31B | $307.00M | $2.38B | $263.00M | (m) | 0.13% | 9.03× | Reported |
| 2025-06-30 | (m) | $222.58B | $244.00M | $2.27B | $215.00M | (m) | 0.11% | 10.58× | Reported |
| 2025-03-31 | (m) | $222.29B | $124.00M | $2.25B | $150.00M | (m) | 0.06% | 14.99× | Reported |
| 2024-12-31 | (m) | $222.28B | $124.00M | $1.89B | $104.00M | (m) | 0.06% | 18.14× | Reported |
| 2024-09-30 | (m) | $224.45B | $122.00M | $1.84B | $72.00M | (m) | 0.05% | 25.60× | Reported |
| 2024-06-30 | (m) | $226.83B | $121.00M | $1.24B | $51.00M | (m) | 0.05% | 24.37× | Reported |
| 2024-03-31 | (m) | $220.57B | $115.00M | $972.00M | $70.00M | (m) | 0.05% | 13.89× | Reported |
| 2023-12-31 | (m) | $216.15B | $105.00M | $1.18B | $65.00M | (m) | 0.05% | 18.11× | Reported |
| 2023-09-30 | (m) | $210.17B | $102.00M | $576.00M | $82.00M | (m) | 0.05% | 7.02× | Reported |
| 2023-06-30 | (m) | $205.01B | $96.00M | $727.00M | $93.00M | (m) | 0.05% | 7.82× | Reported |
| 2023-03-31 | (m) | $198.66B | $85.00M | $626.00M | $112.00M | (m) | 0.04% | 5.59× | Reported |
| 2022-12-31 | (m) | $193.01B | $87.00M | $-43.00M | $122.00M | (m) | 0.05% | -0.35× | Reported |
| 2022-09-30 | (m) | $187.00B | $80.00M | $-874.00M | $134.00M | (m) | 0.04% | -6.52× | Reported |
| 2022-06-30 | (m) | $181.36B | $81.00M | $-596.00M | $149.00M | (m) | 0.04% | -4.00× | Reported |
| 2022-03-31 | (m) | $176.85B | $70.00M | $-470.00M | $159.00M | (m) | 0.04% | -2.96× | Reported |
| 2021-12-31 | (m) | $171.29B | $80.00M | $100.00M | $166.00M | (m) | 0.05% | 0.60× | Reported |
| 2021-09-30 | (m) | $167.37B | $85.00M | $1.51B | $175.00M | (m) | 0.05% | 8.63× | Reported |
| 2021-06-30 | (m) | $162.47B | $89.00M | $472.00M | $180.00M | (m) | 0.05% | 2.62× | Reported |
| 2021-03-31 | (m) | $156.57B | $106.00M | $580.00M | $185.00M | (m) | 0.07% | 3.14× | Reported |
| 2020-12-31 | (m) | $156.45B | $100.00M | $669.00M | $200.00M | (m) | 0.06% | 3.35× | Reported |
| 2020-09-30 | (m) | $154.65B | $98.00M | $542.00M | $217.00M | (m) | 0.06% | 2.50× | Reported |
| 2020-06-30 | (m) | $152.92B | $90.00M | $-4.10B | $238.00M | (m) | 0.06% | -17.22× | Reported |
| 2020-03-31 | (m) | $153.59B | $86.00M | $-4.06B | $256.00M | (m) | 0.06% | -15.86× | Reported |
| 2019-12-31 | (m) | $149.66B | $82.00M | $-4.19B | $271.00M | (m) | 0.05% | -15.46× | Reported |
| 2019-09-30 | (m) | $147.66B | $83.00M | $-4.02B | $283.00M | (m) | 0.06% | -14.20× | Reported |
| 2019-06-30 | (m) | $145.53B | $82.00M | $2.06B | $294.00M | (m) | 0.06% | 7.01× | Reported |
| 2019-03-31 | (m) | $143.53B | $85.00M | $672.00M | $305.00M | (m) | 0.06% | 2.20× | Reported |
| 2018-12-31 | (m) | $141.94B | $86.00M | $785.00M | $313.00M | (m) | 0.06% | 2.51× | Reported |
| 2018-09-30 | (m) | $139.38B | $87.00M | $680.00M | $325.00M | (m) | 0.06% | 2.09× | Reported |
| 2018-06-30 | (m) | $136.81B | $85.00M | $126.00M | $329.00M | (m) | 0.06% | 0.38× | Reported |
| 2018-03-31 | (m) | $134.43B | $87.00M | $1.65B | $318.00M | (m) | 0.06% | 5.17× | Reported |
| 2017-12-31 | (m) | $132.61B | $89.00M | $1.71B | $281.00M | (m) | 0.07% | 6.07× | Reported |
| 2017-09-30 | (m) | $130.58B | $90.00M | $1.85B | $238.00M | (m) | 0.07% | 7.76× | Reported |
| 2017-06-30 | (m) | $129.98B | $96.00M | $2.12B | $201.00M | (m) | 0.07% | 10.55× | Reported |
| 2017-03-31 | (m) | $128.39B | $102.00M | $2.30B | $178.00M | (m) | 0.08% | 12.93× | Reported |
| 2016-12-31 | (m) | $127.24B | $102.00M | $2.35B | $176.00M | (m) | 0.08% | 13.36× | Reported |
| 2016-09-30 | (m) | $125.53B | $104.00M | $2.37B | $178.00M | (m) | 0.08% | 13.34× | Reported |
| 2016-06-30 | (m) | $121.55B | $111.00M | $2.46B | $178.00M | (m) | 0.09% | 13.81× | Reported |
| 2016-03-31 | (m) | $117.71B | $112.00M | $2.40B | $170.00M | (m) | 0.10% | 14.10× | Reported |
| 2015-12-31 | (m) | $112.42B | $113.00M | $2.33B | $161.00M | (m) | 0.10% | 14.48× | Reported |
| 2015-09-30 | (m) | $106.52B | $115.00M | $2.31B | $151.00M | (m) | 0.11% | 15.33× | Reported |
| 2015-06-30 | (m) | $102.53B | $110.00M | $2.16B | $141.00M | (m) | 0.11% | 15.33× | Reported |
| 2015-03-31 | (m) | $97.88B | $104.00M | $1.99B | $138.00M | (m) | 0.11% | 14.42× | Reported |
| 2014-12-31 | (m) | $93.93B | $101.00M | $1.91B | $137.00M | (m) | 0.11% | 13.92× | Reported |
| 2014-09-30 | (m) | $90.63B | $97.00M | $1.88B | $134.00M | (m) | 0.11% | 14.03× | Reported |
| 2014-06-30 | (m) | $91.08B | $96.00M | $1.89B | $133.00M | (m) | 0.11% | 14.17× | Reported |
| 2014-03-31 | (m) | $93.61B | $97.00M | $1.05B | $136.00M | (m) | 0.10% | 7.76× | Reported |
| 2013-12-31 | (m) | $96.73B | $95.00M | $1.02B | $136.00M | (m) | 0.10% | 7.52× | Reported |
| 2013-09-30 | (m) | $99.73B | $93.00M | $1.01B | $130.00M | (m) | 0.09% | 7.77× | Reported |
| 2013-06-30 | (m) | $101.09B | $93.00M | $996.00M | $123.00M | (m) | 0.09% | 8.10× | Reported |
| 2013-03-31 | (m) | $102.44B | $90.00M | $1.84B | $112.00M | (m) | 0.09% | 16.46× | Reported |
| 2012-12-31 | (m) | $104.80B | $89.00M | $1.89B | $102.00M | (m) | 0.08% | 18.56× | Reported |
| 2012-09-30 | (m) | $106.65B | $89.00M | $1.84B | $98.00M | (m) | 0.08% | 18.74× | Reported |
| 2012-06-30 | (m) | $107.55B | $85.00M | $1.79B | $95.00M | (m) | 0.08% | 18.86× | Reported |
| 2012-03-31 | (m) | $107.55B | $82.20M | $1.75B | $94.00M | (m) | 0.08% | 18.59× | Reported |
| 2011-12-31 | (m) | $106.70B | $78.60M | $1.67B | $95.20M | (m) | 0.07% | 17.52× | Reported |
| 2011-09-30 | (m) | $105.00B | $77.90M | $1.56B | $94.30M | (m) | 0.07% | 16.57× | Reported |
| 2011-06-30 | (m) | $102.64B | $79.50M | $1.51B | $92.80M | (m) | 0.08% | 16.31× | Reported |
| 2011-03-31 | (m) | $100.34B | $80.90M | $1.49B | $93.60M | (m) | 0.08% | 15.91× | Reported |
| 2010-12-31 | (m) | $98.61B | $99.80M | $1.41B | $96.10M | (m) | 0.10% | 14.65× | Reported |
| 2010-09-30 | (m) | $98.16B | $98.90M | $1.43B | $101.60M | (m) | 0.10% | 14.08× | Reported |
| 2010-06-30 | (m) | $98.50B | $99.50M | $1.31B | $113.50M | (m) | 0.10% | 11.51× | Reported |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | $95.99B | $109.90M | $1.29B | $114.40M | (m) | 0.11% | 11.25× | Reported |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | $87.41B | $107.90M | $1.39B | $136.10M | (m) | 0.12% | 10.23× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |